Upload
kate-jones
View
87
Download
0
Embed Size (px)
Citation preview
16/10/2013
Inter‐ and intra‐individual variability in biomarker values over a continuous six‐day sampling period
Funded by:
16/10/2013 2© 2013, VITO NV
Introduction t1/2
Exposure frequency
Time
Con
cent
ratio
n
Time
Con
cent
ratio
n
Time
Con
cent
ratio
n
Time
Con
cent
ratio
n
Sho
rtLo
ng
Low
High
16/10/2013 3© 2013, VITO NV
Introduction t1/2
Exposure frequency
Time
Con
cent
ratio
n
Time
Con
cent
ratio
n
Time
Con
cent
ratio
n
Time
Con
cent
ratio
n
Sho
rtLo
ng
Low
High
16/10/2013 4© 2013, VITO NV
Project outline
» CEFIC‐HBM4 project structure
16/10/2013 5© 2013, VITO NV
Project results
» WP3: Human Biomonitoring study
An HBM study will be set up to provide fit‐for‐purpose data for validation ofthe TK‐model. A small number of participants will be asked to collect all urinevoids over the period of a week. Biomarker data will be used to identify howurine collection frequency affects the determination and interpretation ofbiomarker measurements, and to propose optimal sampling strategies infunction of chemical specific characteristics.
16/10/2013 6© 2013, VITO NV
WP3: Human biomonitoring study
» Outline:» 8 individuals were recruited» All urinations were completely collected over a six‐day period» Exposure to personal care products (PCPs) was targeted» Diary with information on food consumption and use of personal care
products (at 30 minute intervals)» Biomarkers included:
» 4 Metals (As, Cd, Mn, Ni)» 15 Organic compounds (9 parabens, triclosan, triclocarban, Benzophenon 1‐3‐8, BPA)
» Creatinin, specific gravity
16/10/2013 7© 2013, VITO NV
WP3: Human biomonitoring study
» Outline:» Exposure to PCPs was based on the ingredient list published on
packages:
Day creamToothpaste
16/10/2013 8© 2013, VITO NV
WP3: Human biomonitoring study
» Exposure to personal care products (PCPs):» Intake moment: inventory of personal care products used» Two sets of products:
» Containing target substances (D‐2 to D1 and D4 to D6)» Free of target substances (D2 and D3)
Product use with target substances
Product use without target substances
Urine collection
16/10/2013 9© 2013, VITO NV
WP3: Human biomonitoring study
» Activity diary:» Included application of PCPs and food consumption
16/10/2013 10© 2013, VITO NV
Participant 1
Participant 2
Participant 3
Participant 4
Participant 5
Participant 6
Participant 7
Participant 8
Gender Female Male Female Male Female Male Female Male
Age 31 38 31 40 58 58 66 66
Length (cm) 170 190 167 184 172 189 163 178
Weight (kg) 58 92 57 85 66 95 63 78
Profession TeacherCivil
servant
Quality control manager
Civil servant
Civil servant
Civil servant
Retired Retired
Smoking No No No No No Yes No NoDietary
supplementsNo No No No Yes No No No
Participant 1
Participant 2
Participant 3
Participant 4
Participant 5
Participant 6
Participant 7
Participant 8
Gender Female Male Female Male Female Male Female Male
Age 31 38 31 40 58 58 66 66
Length (cm) 170 190 167 184 172 189 163 178
Weight (kg) 58 92 57 85 66 95 63 78
Profession TeacherCivil
servant
Qualitycontrol manager
Civil servant
Civil servant
Civilservant
Retired Retired
Smoking No No No No No Yes No NoDietary
supplementsNo No No No Yes No No No
Participant 1
Participant 2
Participant 3
Participant 4
Participant 5
Participant 6
Participant 7
Participant 8
Gender Female Male Female Male Female Male Female Male
Age 31 38 31 40 58 58 66 66
Length (cm) 170 190 167 184 172 189 163 178
Weight (kg) 58 92 57 85 66 95 63 78
Profession TeacherCivil
servant
Quality control manager
Civil servant
Civil servant
Civil servant
Retired Retired
Smoking No No No No No Yes No NoDietary
supplementsNo No No No Yes No No No
Participant 1
Participant 2
Participant 3
Participant 4
Participant 5
Participant 6
Participant 7
Participant 8
Gender Female Male Female Male Female Male Female Male
Age 31 38 31 40 58 58 66 66
Length (cm) 170 190 167 184 172 189 163 178
Weight (kg) 58 92 57 85 66 95 63 78
Profession TeacherCivil
servant
Quality control manager
Civil servant
Civil servant
Civil servant
Retired Retired
Smoking No No No No No Yes No NoDietary
supplementsNo No No No Yes No No No
WP3: Human biomonitoring study
» 8 individuals participated
16/10/2013 11© 2013, VITO NV
WP3: Human biomonitoring study
» Urine collection parameters» In total, 352 samples (not one reported missing, 1 sample incomplete)
Participant 1
Participant 2
Participant 3
Participant 4
Participant 5
Participant 6
Participant 7
Participant 8
# Samples 43 46 40 45 65 34 39 40
Total volume (g) 7748,1 13987,8 7621,4 21047,5 10273,7 8244,9 12541,9 11101,1
Smallest sample (g) 15,8 73,3 40,4 82,9 6,0 93,4 21,4 67,4
Largest sample (g) 774,8 827,7 408,1 986,3 450,6 372,3 781,9 627,0
Size ratio (L/S) 49,0 11,3 10,1 11,9 75,1 4,0 36,5 9,3Avg urine flow rate(g/kg b.w./hour)
1,04 1,38 1,19 2,41 1,29 0,68 1,41 1,21
Urine flow rate ratio (L/S)
24,5 12,4 11,7 16,1 90,1 6,2 15,4 10,8
16/10/2013 12© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements ‐Metals:» Arsenic (t1/2 ≈ 4 days*) At 18:00
Scampi’s for dinner
* Hughes (2006)
Hours since start collection
16/10/2013 13© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Metals» Cadmium (t1/2 ≈ 6‐38 years*) – Environmental exposure, smoking
» Clear diurnal cycle in Cd‐excretion…
* ATSDR (2008)
16/10/2013 14© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Metals» Cadmium – diurnal pattern
0:00-6:00 6:00-10:00 10:00-14:00 14:00-18:00 18:00-0:00
16/10/2013 15© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Organic components» 15 different biomarkers measured
Parabens Benzophenones Others
Compound % < LOQ(range)
Compound % < LOQ Compound % < LOQ Compound % < LOQ
Methyl (LOQ=0,5 µg/l)
0,0 %(0,0 % – 0,0 %)
Butyl(LOQ=0,5 µg/l)
73,9 % BP 1(LOQ=0,5 µg/l)
86,6 % Bisphenol A(LOQ=0,5 µg/l)
26,2 %(1,1 % – 52,9 %)
Ethyl(LOQ=0,5 µg/l)
6,8 %(0,0 % – 31,1 %) Benzyl
(LOQ=0,5 µg/l)95,7 % BP 3
(LOQ=0,5 µg/l)
29,8 %(0,0 % – 91,2 %) Triclosan
(LOQ=0,5 µg/l)
20,5 %(0,0 % – 93,3 %)
Iso‐propyl(LOQ=0,5 µg/l)
100 % Pentyl(LOQ=0,5 µg/l)
100 % BP 8(LOQ=0,5 µg/l)
100 % Triclocarban(LOQ=0,5 µg/l)
100 %
Propyl(LOQ=0,5 µg/l)
29,3 %(0,0 % – 76,5 %) Heptyl
(LOQ=0,5 µg/l)100 %
Iso‐butyl(LOQ=0,5 µg/l)
100 %
16/10/2013 16© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Organic components» Methylparaben exposure
Day cream(D0, 22:30)
Day cream(D4, 7:00)
Day cream(D1, 23:00)
Day cream(D4, 23:00)
Day cream + shower gel + body lotion(D5, 16:30)
Hours since start of urine collection
16/10/2013 17© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Organic components» Methylparaben exposure
Day cream(D0, 22:30)
Day cream(D4, 7:00)
Day cream(D1, 23:00)
Day cream(D4, 23:00)
Day cream + shower gel + body lotion(D5, 16:30)
Shampoo + conditioner + day cream + showergel(D6, 8:30)
16/10/2013 18© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Organic components» Triclosan exposure
16/10/2013 19© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Organic components» Triclosan exposure
» Effect of toothpaste brand !time lag time lag
* Sandborgh‐Englund et al, 2006
10-fold decline over 42 hours ~ 12.5 hr HL, similar to 11h in literature*
16/10/2013 20© 2013, VITO NV
WP3: Human biomonitoring study
» Inter‐ versus intra‐individual variability» Log‐transformation measurements» One‐way random effects ANOVA
» ICC < 0,4 ≈ poor reproducibility» 0,4 < ICC < 0,75 ≈ fair to good reproducibility» ICC > 0,75 ≈ excellent reproducibility
16/10/2013 21© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Metals» Inter‐ versus intra‐individual variability
Arsenic Cadmium Manganese Nickel Creatinin Specific gravity
Expressed as ng/l
Between individual variability 5,26 28,13 24,49 6,60 10,38 0,0039
Within individual variation 45,40 32,97 121,9 31,89 40,98 0,0199
ICC 0,104 0,460 0,167 0,207 0,253 0,196
Expressed as ng/g creatinin
Between individual variability 6,25 20,24 29,18 14,47
Within individual variation 24,25 6,76 74,92 6,87
ICC 0,205 0,750 0,280 0,678
16/10/2013 22© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Metals» Inter‐ versus intra‐individual variability
» High ICC for Cadmium…
58-66 years
30-40 yearsNg/l Ng/g creatinin
8 participants 0,460 0,750
Age 30‐40 0,219 0,075
Age 58‐66 0,407 0,328
16/10/2013 23© 2013, VITO NV
WP3: Human biomonitoring study
» Biomarker measurements – Organic compounds» Inter‐ versus intra‐individual variability
BPA: ICC = 0.15Methyl paraben: ICC = 0.52Triclosan: ICC = 0.92
16/10/2013 24© 2013, VITO NV
Conclusions
» Analyses still in progress» Use of PCP containing target analytes can be detected in urinary
profiles» In many cases rapid rise and subsequent decreases
» Factors influencing variation in spot sample concentrations:» Intra‐individual
» Elimination half‐life in relation to intervals between exposure events» Variation in exposure rates
» Inter‐individual» Variation in exposure rates
16/10/2013 25© 2013, VITO NV
Acknowledgments
» The 8 participants: for collecting urine, carrying around empty and full jars, and filling in the questionnaires;
» The project team: » HSL (UK): Nick Warren, Kevin McNally, John Cocker, Kate Jones» Summit Toxicology (USA): Sean Hays, Lesa Aylward, Chris Kirman» Cranfield University (UK): Len Levy, Ruth Bevan» IPA ‐ Ruhr‐University of Bochum (DE): Holger Koch
» CEFIC: for financial support under the Long Range Initiative (CEFIC‐HBM4)